Drug Profile
DA 5202
Alternative Names: DA-5202Latest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Dong-A ST
- Class Anti-inflammatories; Antirheumatics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Osteoarthritis
Most Recent Events
- 17 Oct 2018 No development reported - Phase-II for Osteoarthritis (In adults, In the elderly) in South Korea (Intra-articular)
- 01 Dec 2014 Phase-II clinical trials in Osteoarthritis (In adults, In the elderly) in South Korea (Intra-articular) (NCT02554240)